Laparoscopic pancreatectomy for benign or low-grade malignant pancreatic tumors: outcomes in a single high-volume institution

Table 1 The demographic characteristics of all patients

Variables	Mean ± SD or median (IQR) or case number
Cases (Total)	144
LPPPD	83 (57.6%)
LSPDP	41 (28.5%)
LCP	20 (13.9%)
Sex (male/female)	53/91
Age (years, IQR)	53.0 (39.3–63.0)
BMI (Kg/m², IQR)	21.5 (19.7–24.0)
ASA score
II (n, %)	134 (93.1%)
III (n, %)	10 (6.9%)
Comorbidities* (n, %)	36 (25.0%)
History of abdominal surgery^† (n, %)	27 (18.8%)
Hemoglobin (g/L, mean ± SD)	126.2 ± 16.8
Albumin (g/L, mean ± SD)	41.8 ± 3.7
Creatinine (μmol/L, IQR)	87.0 (69.0–98.0)
Pathological diagnosis
Intraductal papillary mucinous neoplasm^‡	39 (27.1%)
Solid pseudopapillary tumor	24 (16.7%)
Cystadenoma (mucinous/serous)	52 (34/18, 36.1%)
Neuroendocrine tumor^§	29 (20.1%)

SD standard deviation, IQR interquartile range, LPPPD laparoscopic pylorus-preserving pancreaticoduodenectomy, LSPDP laparoscopic spleen-preserving distal pancreatectomy, LCP laparoscopic central pancreatectomy, BMI body mass index, ASA score American Society of Anesthesiologists classification score
*Comorbidities including chronic obstructive pulmonary disease, hypertension, diabetes and cardiovascular disease
^†History of abdominal surgery including cholecystectomy, appendectomy, biliary tract and gastric surgery
^‡Only including low-grade and moderate-grade dysplasia
^§Only including G1 and G2

ISSN: 1471-2482